Edition:
India

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

3.64USD
17 Nov 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.64
Open
$3.61
Day's High
$3.70
Day's Low
$3.57
Volume
416
Avg. Vol
6,368
52-wk High
$4.75
52-wk Low
$1.75

Chart for

About

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients... (more)
No analyst recommendations are available for .

Overall

Beta: -0.44
Market Cap(Mil.): $38.23
Shares Outstanding(Mil.): 10.99
Dividend: --
Yield (%): --

Financials

BRIEF-Champions Biotechnology reports Q1 loss per share $0.06

* Champions Oncology reports record quarterly revenue of $5 million

15 Sep 2017

BRIEF-Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of PDX models

* Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of patient-derived xenograft (PDX) models

21 Aug 2017

BRIEF-Champions Oncology to collaborate with Addario Lung Cancer Medical Institute

* Champions Oncology announces research collaboration with the Addario Lung Cancer Medical Institute to develop unique cohort of patient-derived xenograft (PDX) models

18 Aug 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $138.00 -0.87
Abbott Laboratories (ABT.N) $55.56 +0.02
Bayer AG (BAYGn.DE) €107.55 -0.35
Bayer AG (BAYE.F) -- --
GlaxoSmithKline plc (GSK.L) 1,308.00 --
Biocon Ltd (BION.NS) Rs394.35 +11.90

Earnings vs. Estimates

No consensus analysis data available.